PELVIC: Cross-cultural Adaptation and Validation of the Pelvic Girdle Questionnaire in French Language

Sponsor
University Hospital, Caen (Other)
Overall Status
Recruiting
CT.gov ID
NCT03436888
Collaborator
(none)
250
2
51.5
125
2.4

Study Details

Study Description

Brief Summary

The objective of this study is the adaptation of the Pelvic Girdle Questionnaire to the French language from France, and the analysis of its psychometric properties. Firstly, a translation and adaptation process will be performed according to international guidelines. Secondly, the validation process will be performed through a sample of 250 pregnant or postpartum women suffering from pelvic girdle pain. They will fill several questionnaires, including Pelvic Girdle Questionnaire, that will allow us to analyse psychometric properties of the French version.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    250 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Cross-cultural Adaptation and Validation of the Pelvic Girdle Questionnaire in French Language
    Actual Study Start Date :
    Mar 15, 2018
    Anticipated Primary Completion Date :
    Jul 1, 2022
    Anticipated Study Completion Date :
    Jul 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Disability [up to ten days]

      Disability will be measured using Pelvic Girdle Questionnaire

    Secondary Outcome Measures

    1. Disability: Oswestry disability index [1 day (First appointment)]

      Disability will be measured using Oswestry disability index

    2. fear-avoidance beliefs: Fear Avoidance Beliefs Questionnaire [1 day (First appointment)]

      Fear Avoidance Beliefs will be measured using Fear Avoidance Beliefs Questionnaire

    3. Pain Catastrophizing: Pain catastrophizing scale [1 day (First appointment)]

      Pain catastrophizing will be measured using pain catastrophizing scale

    4. health-related quality of life: SF 8 scale [1 day (First appointment)]

      Health-related quality of life will be measured using SF 8 scale

    5. Pain: Visual Analogue Pain Rating Scale [1 day (First appointment)]

      Pain will be measured using Visual Analogue Pain Rating Scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women from 18 years-old, pregnant or having given birth less than one year earlier, with PGP whose onset occurred during pregnancy or within 3 weeks after birth. Registered in the French social security system.
    Exclusion Criteria:
    • Ovarian cysts, uterine fibroids, caesarean section (if subject in postpartum period), radicular pain below the knee, previous surgery on the spine, pelvis or lower limbs, vaginismus-type pelvic pain, spondylolisthesis, inflammatory diseases, prolapse, suspected serious pathology (weakness of the lower limbs, reflex changes or loss of sensation associated with the same spinal nerve), impossibility or difficulty in understanding the questionnaires and subjects needing guardianship/supervision.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pôle de Santé de la Grâce de Dieu Caen France 14000
    2 Caen University Hospital Caen France 14033

    Sponsors and Collaborators

    • University Hospital, Caen

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Caen
    ClinicalTrials.gov Identifier:
    NCT03436888
    Other Study ID Numbers:
    • 2017-A00949-44
    First Posted:
    Feb 19, 2018
    Last Update Posted:
    Mar 3, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 3, 2022